Sponsor or institution

Clinical trials and research at Chengdu Kangnuoxing Biopharma,Inc.

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Adolescent seasonal allergic rhinitis: add-on therapy with stapokibart vs placebo

  This phase 3 trial tests whether adding stapokibart to standard care helps adolescents aged 12–17 with seasonal allergic rhinitis.

  Recruiting Phase 3 Chengdu Kangnuoxing Biopharma,Inc. · Beijing, Beijing Municipality and 26 other locations · NCT07678931

• Stapokibart Injection for atopic dermatitis in adults

  This study tests Stapokibart Injection in adults with atopic dermatitis to see how safe it is and whether it helps.

  Recruiting Chengdu Kangnuoxing Biopharma,Inc. · Beijing, Beijing Municipality · NCT07544862

Quick answers

How many clinical trials run by Chengdu Kangnuoxing Biopharma,Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →